CRIS Current Research Information System

DIEMBERGER, IGOR
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 15.747
NA - Nord America 14.229
EU - Europa 12.077
SA - Sud America 946
AF - Africa 772
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 9
Totale 43.806
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.076
VN - Vietnam 4.360
SG - Singapore 4.291
CN - Cina 3.762
GB - Regno Unito 2.436
IT - Italia 2.297
DE - Germania 1.793
NL - Olanda 1.287
HK - Hong Kong 1.162
SE - Svezia 825
FR - Francia 802
IN - India 736
RU - Federazione Russa 679
BR - Brasile 674
UA - Ucraina 656
KR - Corea 396
IE - Irlanda 361
JP - Giappone 281
CI - Costa d'Avorio 253
FI - Finlandia 239
ZA - Sudafrica 209
EE - Estonia 198
AR - Argentina 125
TG - Togo 112
BG - Bulgaria 98
ID - Indonesia 96
PH - Filippine 90
CH - Svizzera 88
JO - Giordania 84
SC - Seychelles 82
BD - Bangladesh 81
CA - Canada 73
AT - Austria 70
IQ - Iraq 70
TH - Thailandia 60
PL - Polonia 53
MX - Messico 48
TR - Turchia 44
PK - Pakistan 43
TW - Taiwan 39
BE - Belgio 38
EC - Ecuador 37
NG - Nigeria 37
ES - Italia 31
IR - Iran 30
GR - Grecia 27
SA - Arabia Saudita 27
CL - Cile 26
CO - Colombia 25
AU - Australia 24
PY - Paraguay 21
EG - Egitto 18
RO - Romania 18
VE - Venezuela 16
UZ - Uzbekistan 15
MA - Marocco 14
LT - Lituania 11
PE - Perù 11
TN - Tunisia 11
MY - Malesia 10
UY - Uruguay 10
AE - Emirati Arabi Uniti 9
DO - Repubblica Dominicana 9
LB - Libano 9
KE - Kenya 8
AZ - Azerbaigian 7
AL - Albania 6
DK - Danimarca 6
EU - Europa 6
IL - Israele 6
MN - Mongolia 6
NP - Nepal 6
OM - Oman 6
RS - Serbia 6
SK - Slovacchia (Repubblica Slovacca) 6
DZ - Algeria 5
HR - Croazia 5
HU - Ungheria 5
JM - Giamaica 5
KZ - Kazakistan 5
PT - Portogallo 5
BY - Bielorussia 4
CZ - Repubblica Ceca 4
ET - Etiopia 4
NO - Norvegia 4
SI - Slovenia 4
SN - Senegal 4
AO - Angola 3
CR - Costa Rica 3
HN - Honduras 3
LU - Lussemburgo 3
PR - Porto Rico 3
SM - San Marino 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
CY - Cipro 2
GA - Gabon 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MD - Moldavia 2
Totale 43.768
Salva come PNG Salva come JPEG
Città #
Singapore 2.992
Southend 2.106
Ashburn 1.511
Fairfield 1.363
Hong Kong 1.102
San Jose 1.080
Ho Chi Minh City 945
Hefei 865
Hanoi 732
Chandler 724
Santa Clara 700
Woodbridge 670
Kerkrade 652
Wilmington 622
Seattle 582
Princeton 561
Houston 554
Dong Ket 497
Jacksonville 451
Cambridge 446
Frankfurt am Main 433
Beijing 409
Boardman 367
Dublin 361
Seoul 355
Eygelshoven 338
Lauterbourg 336
Ann Arbor 326
Bologna 268
Los Angeles 264
Abidjan 253
Tokyo 243
Westminster 231
Nanjing 211
Padova 198
Milan 194
Helsinki 190
Berlin 171
Dallas 148
Rome 137
Saint Petersburg 134
New York 131
Jinan 127
Haiphong 125
Buffalo 124
Da Nang 122
Shenyang 113
Lomé 112
Redondo Beach 105
Sofia 93
Council Bluffs 91
Medford 90
San Diego 89
Bremen 88
Changsha 87
São Paulo 86
Bengaluru 84
Amman 80
Mülheim 79
The Dalles 78
Turin 76
Guangzhou 71
Munich 70
Nanchang 68
Des Moines 64
Hebei 64
Redmond 61
Bern 57
Mahé 57
Chicago 54
Nuremberg 54
Biên Hòa 52
Tianjin 49
Zhengzhou 49
Jiaxing 47
Shanghai 47
Hải Dương 43
Jakarta 43
London 42
Hangzhou 41
Yubileyny 40
Can Tho 38
Olalla 38
Naples 37
Warsaw 36
Abeokuta 35
Ninh Bình 35
Bari 34
Brussels 34
Ningbo 34
Dearborn 33
Lappeenranta 33
Falkenstein 32
Phoenix 31
Verona 31
Johannesburg 30
Quận Bình Thạnh 29
Taizhou 29
Vienna 29
Düsseldorf 28
Totale 28.401
Salva come PNG Salva come JPEG
Nome #
'Real-World' antithrombotic treatment in atrial fibrillation: The eorp-af pilot survey 1.690
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 1.083
Adverse events with sacubitril/valsartan in the real world: emerging signals to target preventive strategies from the FDA adverse event reporting system 305
Acute and chronic haemodynamic effects of biventricular pacing and of switching to different pacing modalities in heart failure patients 298
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 286
Asymptomatic Atrial Fibrillation: Clinical Correlates, Management, and Outcomes in the EORP-AF Pilot General Registry 266
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 246
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 245
Automated CO2 angiography: Injection pressure and volume settings 238
Bridging the future of cardiac stimulation: physiologic or leadless pacing? 232
Atrial fibrillation: it is better to be alone than in bad company! 230
P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. 228
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 226
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 221
Changes to oral anticoagulant therapy and risk of death over a 3-year follow-up of a contemporary cohort of European patients with atrial fibrillation final report of the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) pilot general registry 219
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 216
AF burden is important - Fact or fiction? 214
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 206
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 204
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 203
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 199
Electrocardiographic remodeling during cardiac resynchronization therapy 198
Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study 198
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 197
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 196
Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study 195
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 195
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 193
Cardiac resynchronization therapy: a comparison among left ventricular bipolar, quadripolar and active fixation leads 193
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 192
Exploring Microphone Technologies for Digital Auscultation Devices 191
Farmaci antiaritmici 189
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 189
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 189
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 189
Use of antihistamines and risk of ventricular tachyarrhythmia: a nested case-control study in five European countries from the ARITMO project. 188
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System 188
Atrial fibrillation ablation: beyond electro-mechanical matters 184
A Randomized Study of Cardiac Resynchronization Therapy Defibrillator Versus Dual-Chamber Implantable Cardioverter-Defibrillator in Ischemic Cardiomyopathy With Narrow QRS: The NARROW-CRT Study 183
Drug-induced Kounis syndrome: A matter of pharmacovigilance 183
Holter ECG for pacemaker/defibrillator carriers: What is its role in the era of remote monitoring? 181
Comparison Between a Single-Lead ECG Garment Device and a Holter Monitor: A Signal Quality Assessment 180
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 179
Cardiac resynchronization therapy in persistent left superior vena cava: Can you do it two-leads-only? 179
Pharmacological cardioversion of atrial fibrillation : current management and treatment options. 178
Wireless Endocardial Atrial (and Ventricular) Sensing with no Implanted Power Source: a Proposal 177
Implantation of cardioverter-defibrillator: Effects on shoulder function. 176
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 176
Is Less Always More? A Prospective Two-Centre Study Addressing Clinical Outcomes in Leadless versus Transvenous Single-Chamber Pacemaker Recipients 173
BLOCK HF: how far does it extend indications for cardiac resynchronization therapy? 173
Preoperative checklist to reduce the risk of cardiac implantable electronic device infections 173
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 172
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 172
'Real-world' management and outcomes of patients with paroxysmal vs. non-paroxysmal atrial fibrillation in Europe: The EURObservational Research Programme-Atrial Fibrillation (EORP-AF) General Pilot Registry 171
Evaluating sacubitril/valsartan as a treatment option for heart failure with reduced ejection fraction and preserved ejection fraction 171
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 170
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 170
Cardiac resynchronization therapy: effects on left and right ventricular ejection fraction during exercise. 170
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 169
Outcomes with dronedarone in atrial fibrillation: What differences between real-world practice and trials? A meta-analysis and meta-regression analysis 169
The "Subtle" connection between development of cardiac implantable electrical device infection and survival after complete system removal: An observational prospective multicenter study 168
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 165
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 165
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 165
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 165
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 165
Is ventricular sensing always right, when it is left? 164
Predictors of long-term survival free from relapses after extraction of infected CIED. 163
Biventricular Pacing: Electrocardiographic Versus Structural Remodeling 162
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 162
Glomerular filtration rate in patients with atrial fibrillation and 1-year outcomes 160
Improving Auscultation in Wearable Health Devices Integrating MEMS Microphones and Accelerometers 159
Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry 158
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 158
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 157
Cardioversione atriale interna: valutazione prospettica dei fattori determinanti il dolore indotto dallo shock. 156
The effects of gender on electrical therapies for the heart: physiology, epidemiology, and access to therapies 156
Recurrence of pericarditis after influenza vaccination: a case report and review of the literature 156
Self-reported physical activity and major adverse events in patients with atrial fibrillation: A report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry 156
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis 155
L'ottimizzazione degli intervalli AV e VV nei pazienti con device biventricolare: revisione della letteratura e contributo sperimentale 155
Cardiac resynchronization therapy and cardiac sympathetic function. 155
Atrial fibrillation and heart failure: does one epidemic feed he other? 155
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 154
Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices 153
Neurohormones and inflammatory mediators in patients with heart failure undergoing cardiac resynchronization therapy: Time courses and prediction of response. 152
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations 152
Influenza Vaccination and Myo-Pericarditis in Patients Receiving Immune Checkpoint Inhibitors: Investigating the Likelihood of Interaction through the Vaccine Adverse Event Reporting System and VigiBase 152
The QRS interval in patients treated with resynchronization therapy: which value 151
QRS pattern and improvement in right and left ventricular function after cardiac resynchronization therapy: a radionuclide study 151
Long-Term Atrioventricular Block Following Valve Surgery: Electrocardiographic and Surgical Predictors 150
Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669,000 patients 150
Phrenic stimulation: a challenge for cardiac resynchronization therapy 149
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 149
Non-valvular atrial fibrillation: Potential clinical implications of the heterogeneous definitions used in trials on new oral anticoagulants 148
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia 148
Impact of renal impairment on atrial fibrillation: ESC-EHRA EORP-AF Long-Term General Registry 147
Less is more: Can we achieve cardiac resynchronization with 2 leads only? 147
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 147
Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy. 147
Totale 20.591
Salva come PNG Salva come JPEG
Categoria #
all - tutte 112.530
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 112.530
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.773 0 0 0 0 0 0 0 0 0 188 159 1.426
2021/20224.139 344 187 262 318 422 252 113 377 162 196 743 763
2022/20234.512 444 561 212 594 268 274 157 236 826 248 347 345
2023/20241.561 125 217 109 116 152 293 92 122 72 110 68 85
2024/20256.557 293 1.233 521 468 1.047 289 349 161 96 401 386 1.313
2025/202616.282 1.653 1.689 1.570 1.230 1.472 1.842 2.227 1.091 2.544 964 0 0
Totale 44.651